Issues & Advocacy

HOME > ADVOCACY

In This Section

Issues & Advocacy

SNMMI's mission with regard to health policy and regulatory affairs is to enhance its credibility, advance its issues, and through leadership become a valued partner among public policy stakeholders.

LATEST NEWS

August 14, 2019 — NRC Seeks Comments for Proposed Revision of Patient Release Guidance
The U.S. Nuclear Regulatory Commission (NRC) is seeking comments for a proposed revision (Revision 1) of the draft regulatory guide DG-8057, “Release of Patients Administered Radioactive Material.”
August 9, 2019 — NRC Releases Updated Licensing Guidance for Ge-68/Ga-68 Generators
Recently, the Nuclear Regulatory Commission (NRC) updated licensing guidance of germanium-68/gallium-68 (Ge-68/Ga-68) pharmaceutical-grade generators. The new guidance is an update to the 2017 guidance.
August 2, 2019 — CMS Issues 2020 Payment Rules
The Centers for Medicare and Medicaid Services released the calendar year 2020 Medicare Physician Fee Schedule and Hospital Outpatient Prospective Payment System proposed rules on Monday, July 29, 2019.
July 31, 2019 — SNMMI Launches Grassroots Movement
On Monday, July 29 SNMMI launched a letter writing campaign in support of H.R. 3772, the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019.
July 24, 2019 — WATCH: SNMMI Members Talk Nuclear Medicine at Congressional Policy Briefing on Capitol Hill
On July 17, SNMMI, with MITA and CORAR, co-hosted a congressional policy briefing to discuss precision medicine and the importance of diagnostic radiopharmaceuticals.
July 17, 2019 — Bipartisan Group Moves to Expand Access to Diagnostic Radiopharmaceuticals
On July 16, a bipartisan group introduced the Medicare Diagnostic Radiopharmaceutical Payment Equity Act of 2019 (HR 3772). The bill would expand patient access to highly targeted, precision diagnostic radiopharmaceuticals that evaluate conditions such as Alzheimer’s disease, Parkinson’s disease, and some cancers—allowing patients to get the right treatment faster and saving taxpayers money.
July 5, 2019 — SNMMI-ACNM Submit Comments on NRC Proposed Changes to Training and Experience Requirements
SNMMI together with representatives from ACNM provided feedback to the NRC on the proposed changes to the training and experience requirements for those who wish to be authorized users of unsealed byproduct material.
June 5, 2019 — USP Publishes General Chapter <825> Effective December 1, 2019
On June 1, the U.S. Pharmacopeia (USP) published General Chapter <825> Radiopharmaceuticals – Preparation, Compounding, Dispensing, and Repackaging. This General Chapter provides uniform minimum standards for the preparation, compounding, dispensing, and repackaging of sterile and non-sterile radiopharmaceuticals for humans and animals that occur as part of state-licensed activities.

Click For More Government Relations News